Brief: CNS Pharma - Nasdaq Has Halted Trading In Co's Common Stock
May 18 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* PENDING RECEIPT OF ADDITIONAL INFORMATION FROM COMPANY,
NASDAQ
HAS HALTED TRADING IN CO'S COMMON STOCK
* CNS PHARMACEUTICALS- CO IS ACTIVELY WORKING WITH STAFF OF
NASDAQ
TO PROVIDE IT WITH ALL REQUESTED INFORMATION, AND HOPES TO BEGIN
TRADING SOON
Source text for Eikon: ID:nPn91pvj4a
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026